Measuring Drug Occupancy in the Absence of a Reference Region: The Lassen Plot Re-Visited

Quantitative estimation of neuroreceptor occupancy by exogenous drugs using positron emission tomography is based on the reduction in the total volume of distribution (VT) of site-specific radioligands after drug administration. An estimate of the distribution volume of free and nonspecifically boun...

Full description

Saved in:
Bibliographic Details
Published inJournal of cerebral blood flow and metabolism Vol. 30; no. 1; pp. 46 - 50
Main Authors Cunningham, Vincent J, Rabiner, Eugenii A, Slifstein, Mark, Laruelle, Marc, Gunn, Roger N
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.01.2010
Nature Publishing Group
Sage Publications Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Quantitative estimation of neuroreceptor occupancy by exogenous drugs using positron emission tomography is based on the reduction in the total volume of distribution (VT) of site-specific radioligands after drug administration. An estimate of the distribution volume of free and nonspecifically bound radioligand (VND) is also required to distinguish specific from total binding. However, a true reference region, devoid of specific binding, is often not available. We present a transformation of a graphical method, originally introduced by Lassen, using regional estimates of VT alone to determine occupancy, together with an extension that does not require baseline data.
AbstractList Quantitative estimation of neuroreceptor occupancy by exogenous drugs using positron emission tomography is based on the reduction in the total volume of distribution ( V T ) of site-specific radioligands after drug administration. An estimate of the distribution volume of free and nonspecifically bound radioligand ( V ND ) is also required to distinguish specific from total binding. However, a true reference region, devoid of specific binding, is often not available. We present a transformation of a graphical method, originally introduced by Lassen, using regional estimates of V T alone to determine occupancy, together with an extension that does not require baseline data.
Quantitative estimation of neuroreceptor occupancy by exogenous drugs using positron emission tomography is based on the reduction in the total volume of distribution (V sub(T)) of site-specific radioligands after drug administration. An estimate of the distribution volume of free and nonspecifically bound radioligand (V sub(ND)) is also required to distinguish specific from total binding. However, a true reference region, devoid of specific binding, is often not available. We present a transformation of a graphical method, originally introduced by Lassen, using regional estimates of V sub(T) alone to determine occupancy, together with an extension that does not require baseline data.
Quantitative estimation of neuroreceptor occupancy by exogenous drugs using positron emission tomography is based on the reduction in the total volume of distribution (VT) of site-specific radioligands after drug administration. An estimate of the distribution volume of free and nonspecifically bound radioligand (VND) is also required to distinguish specific from total binding. However, a true reference region, devoid of specific binding, is often not available. We present a transformation of a graphical method, originally introduced by Lassen, using regional estimates of VT alone to determine occupancy, together with an extension that does not require baseline data.
Quantitative estimation of neuroreceptor occupancy by exogenous drugs using positron emission tomography is based on the reduction in the total volume of distribution (V(T)) of site-specific radioligands after drug administration. An estimate of the distribution volume of free and nonspecifically bound radioligand (V(ND)) is also required to distinguish specific from total binding. However, a true reference region, devoid of specific binding, is often not available. We present a transformation of a graphical method, originally introduced by Lassen, using regional estimates of V(T) alone to determine occupancy, together with an extension that does not require baseline data.
Quantitative estimation of neuroreceptor occupancy by exogenous drugs using positron emission tomography is based on the reduction in the total volume of distribution (V(T)) of site-specific radioligands after drug administration. An estimate of the distribution volume of free and nonspecifically bound radioligand (V(ND)) is also required to distinguish specific from total binding. However, a true reference region, devoid of specific binding, is often not available. We present a transformation of a graphical method, originally introduced by Lassen, using regional estimates of V(T) alone to determine occupancy, together with an extension that does not require baseline data.Quantitative estimation of neuroreceptor occupancy by exogenous drugs using positron emission tomography is based on the reduction in the total volume of distribution (V(T)) of site-specific radioligands after drug administration. An estimate of the distribution volume of free and nonspecifically bound radioligand (V(ND)) is also required to distinguish specific from total binding. However, a true reference region, devoid of specific binding, is often not available. We present a transformation of a graphical method, originally introduced by Lassen, using regional estimates of V(T) alone to determine occupancy, together with an extension that does not require baseline data.
Author Rabiner, Eugenii A
Laruelle, Marc
Cunningham, Vincent J
Gunn, Roger N
Slifstein, Mark
Author_xml – sequence: 1
  givenname: Vincent J
  surname: Cunningham
  fullname: Cunningham, Vincent J
  email: vincent.j.cunningham@gsk.com
– sequence: 2
  givenname: Eugenii A
  surname: Rabiner
  fullname: Rabiner, Eugenii A
– sequence: 3
  givenname: Mark
  surname: Slifstein
  fullname: Slifstein, Mark
– sequence: 4
  givenname: Marc
  surname: Laruelle
  fullname: Laruelle, Marc
– sequence: 5
  givenname: Roger N
  surname: Gunn
  fullname: Gunn, Roger N
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22499631$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19738632$$D View this record in MEDLINE/PubMed
BookMark eNp9kt9rFDEQx4NU7LX66qMEwfoge-bH7mbjg1DqTziplCr6FJLc7DbHXnImu4X-92Z7Z6uF-hQm-cz3O5mZA7TngweEnlIyp4Q3r1fWtOs5I0TOqSQP0IxWlSwEofUemhEmaFGL5sc-OkhpRQhpeFU9QvtUCt7UnM3Qzy-g0xid7_C7OHb41Npxo729ws7j4QLwsUngLeDQYo3PoIV4HZ5B54J_g88zstApM_hrH4Z8X3x3yQ2wfIwetrpP8GR3HqJvH96fn3wqFqcfP58cLwpbCTnkUrUkpaaSSmuXNalLSSmT1dKQlhrRUJJjIa0xJWvBmEZDU5a0ZlZWggLhh-jtVnczmjUsLfgh6l5tolvreKWCdurfF-8uVBcuFZOT1STwcicQw68R0qDWLlnoe-0hjEkJzmtKBOOZPPovySjnrKyaDD6_A67CGH1uQ2ayLanE5Pvs78JvKv4znAy82AE6Wd23Mc_FpRuOsVLKmtPMzbecjSGlCO2tFFHTlqjrLVHTlmT1ybm8k2DdoIc80Nwg19-f9mqblnQHtz-6h_4NHIbNTQ
CODEN JCBMDN
CitedBy_id crossref_primary_10_1021_acschemneuro_9b00618
crossref_primary_10_1007_s00259_017_3621_8
crossref_primary_10_1021_acschemneuro_8b00526
crossref_primary_10_1038_jcbfm_2014_46
crossref_primary_10_1016_j_neuroimage_2016_01_058
crossref_primary_10_1021_acs_molpharmaceut_3c00750
crossref_primary_10_1002_syn_21579
crossref_primary_10_2967_jnumed_124_267928
crossref_primary_10_1176_appi_ajp_2014_13121581
crossref_primary_10_3390_molecules201018387
crossref_primary_10_2967_jnumed_118_222034
crossref_primary_10_1021_acschemneuro_0c00074
crossref_primary_10_1093_ntr_ntx091
crossref_primary_10_2967_jnumed_124_268455
crossref_primary_10_1007_s11307_020_01506_8
crossref_primary_10_2967_jnumed_120_249144
crossref_primary_10_2967_jnumed_111_088815
crossref_primary_10_1017_S1461145712001411
crossref_primary_10_1177_0271678X20928149
crossref_primary_10_1002_syn_20926
crossref_primary_10_1118_1_3578606
crossref_primary_10_2967_jnumed_123_265912
crossref_primary_10_1007_s11307_014_0808_2
crossref_primary_10_1016_j_bja_2020_08_052
crossref_primary_10_1016_j_neuroimage_2022_119195
crossref_primary_10_2967_jnumed_115_161083
crossref_primary_10_2967_jnumed_120_256008
crossref_primary_10_1007_s00259_022_05698_9
crossref_primary_10_1038_jcbfm_2014_65
crossref_primary_10_1038_jcbfm_2014_68
crossref_primary_10_1021_acschemneuro_3c00332
crossref_primary_10_1016_j_nucmedbio_2011_04_006
crossref_primary_10_1016_j_nucmedbio_2015_04_004
crossref_primary_10_2967_jnumed_112_108258
crossref_primary_10_1186_s40658_022_00464_0
crossref_primary_10_1007_s00259_010_1723_7
crossref_primary_10_1016_j_ddtec_2012_01_001
crossref_primary_10_1007_s00213_012_2733_x
crossref_primary_10_1177_0271678X19864081
crossref_primary_10_3389_fnins_2022_943512
crossref_primary_10_1007_s00259_021_05597_5
crossref_primary_10_1002_syn_21792
crossref_primary_10_2967_jnumed_116_188052
crossref_primary_10_1007_s11307_019_01387_6
crossref_primary_10_1002_syn_22096
crossref_primary_10_2967_jnumed_122_264061
crossref_primary_10_1038_s41380_020_0811_8
crossref_primary_10_1021_acs_molpharmaceut_8b01209
crossref_primary_10_2967_jnumed_118_217372
crossref_primary_10_1016_j_euroneuro_2020_11_013
crossref_primary_10_1007_s00259_018_4119_8
crossref_primary_10_1186_s13550_015_0119_x
crossref_primary_10_1016_j_neuroimage_2017_02_022
crossref_primary_10_2967_jnumed_115_168179
crossref_primary_10_1016_j_neuroimage_2012_02_085
crossref_primary_10_2967_jnumed_117_204453
crossref_primary_10_1186_s13550_016_0170_2
crossref_primary_10_1038_mp_2012_78
crossref_primary_10_1016_j_neuroimage_2014_05_033
crossref_primary_10_1002_syn_21656
crossref_primary_10_1007_s00213_015_3997_8
crossref_primary_10_1002_syn_21775
crossref_primary_10_1002_syn_21896
crossref_primary_10_1186_s13550_014_0076_9
crossref_primary_10_2967_jnumed_123_266750
crossref_primary_10_1007_s11307_019_01323_8
crossref_primary_10_2967_jnumed_113_132712
crossref_primary_10_1016_j_neuroimage_2013_08_001
crossref_primary_10_1038_s41598_017_16020_1
crossref_primary_10_1021_acschemneuro_5b00066
crossref_primary_10_3389_fnume_2022_1030387
crossref_primary_10_1016_j_neuroimage_2016_11_035
crossref_primary_10_1016_j_neuropharm_2017_01_016
crossref_primary_10_1007_s00259_024_06759_x
crossref_primary_10_1021_acschemneuro_8b00715
crossref_primary_10_1007_s00259_016_3544_9
crossref_primary_10_1177_0271678X241291949
crossref_primary_10_1177_0271678X231168591
crossref_primary_10_2967_jnumed_113_121020
crossref_primary_10_2967_jnumed_113_131854
crossref_primary_10_1111_bph_12505
crossref_primary_10_1016_j_neuropharm_2018_03_039
crossref_primary_10_1021_acs_molpharmaceut_2c00121
crossref_primary_10_1016_j_neuroimage_2022_119620
crossref_primary_10_2967_jnumed_118_220517
crossref_primary_10_1007_s00210_024_03323_0
crossref_primary_10_1177_1536012117731258
crossref_primary_10_1038_jcbfm_2012_80
crossref_primary_10_1371_journal_pbio_3002445
crossref_primary_10_1186_s13550_024_01117_2
crossref_primary_10_2967_jnumed_118_212696
crossref_primary_10_2967_jnumed_118_219766
crossref_primary_10_1176_appi_ajp_2012_12060793
crossref_primary_10_1002_syn_21879
crossref_primary_10_1007_s11307_018_1260_5
crossref_primary_10_1007_s00259_023_06270_9
crossref_primary_10_1038_s41386_019_0398_4
crossref_primary_10_1124_jpet_115_229278
crossref_primary_10_2967_jnumed_109_072447
crossref_primary_10_1017_S1461145710001227
crossref_primary_10_1177_0271678X16629483
crossref_primary_10_1007_s00259_021_05248_9
crossref_primary_10_1007_s00213_014_3533_2
crossref_primary_10_1007_s11307_016_0999_9
crossref_primary_10_1186_s13550_020_00657_7
crossref_primary_10_1038_npp_2012_212
crossref_primary_10_1111_epi_14701
crossref_primary_10_1177_0271678X221084416
crossref_primary_10_1002_syn_21643
crossref_primary_10_3109_00498254_2016_1166531
crossref_primary_10_1124_jpet_120_000371
crossref_primary_10_2967_jnumed_122_263977
crossref_primary_10_1016_j_nucmedbio_2014_01_007
crossref_primary_10_1007_s00259_015_3209_0
crossref_primary_10_1523_JNEUROSCI_1657_21_2021
crossref_primary_10_1038_jcbfm_2011_108
crossref_primary_10_1177_0271678X16650697
crossref_primary_10_1177_0271678X20950486
crossref_primary_10_1111_jnc_14291
crossref_primary_10_2967_jnumed_113_130294
crossref_primary_10_1007_s11307_024_01979_x
crossref_primary_10_1038_jcbfm_2010_83
crossref_primary_10_2967_jnumed_116_174151
crossref_primary_10_1002_syn_21613
crossref_primary_10_3389_fnimg_2024_1358221
crossref_primary_10_2967_jnumed_121_263200
crossref_primary_10_1186_s13550_017_0334_8
crossref_primary_10_2967_jnumed_118_208009
crossref_primary_10_2967_jnumed_116_178996
crossref_primary_10_1016_j_euroneuro_2019_09_813
crossref_primary_10_1177_0271678X16668891
crossref_primary_10_1007_s00213_015_3938_6
crossref_primary_10_1038_s41401_024_01375_9
crossref_primary_10_1007_s00259_021_05571_1
crossref_primary_10_1016_j_nucmedbio_2011_02_005
crossref_primary_10_1109_TBME_2024_3486191
crossref_primary_10_1177_0271678X241254679
crossref_primary_10_1007_s00259_021_05327_x
crossref_primary_10_1007_s00259_024_07013_0
crossref_primary_10_2310_7290_2014_00004
crossref_primary_10_1007_s00259_017_3879_x
crossref_primary_10_2967_jnumed_115_162461
crossref_primary_10_1007_s00259_023_06162_y
crossref_primary_10_1088_0031_9155_60_22_R363
crossref_primary_10_2967_jnumed_120_246967
crossref_primary_10_1038_jcbfm_2014_225
crossref_primary_10_1007_s11307_018_1168_0
crossref_primary_10_1007_s11307_021_01698_7
crossref_primary_10_1007_s00259_023_06487_8
crossref_primary_10_1177_0271678X211058285
crossref_primary_10_1146_annurev_bioeng_062117_121056
crossref_primary_10_1007_s10928_015_9410_8
crossref_primary_10_1111_bcp_14952
crossref_primary_10_1371_journal_pone_0176636
crossref_primary_10_2967_jnumed_112_109512
crossref_primary_10_1007_s11307_013_0633_z
crossref_primary_10_1002_syn_21721
crossref_primary_10_1177_0271678X231205661
crossref_primary_10_1007_s00213_010_1824_9
crossref_primary_10_1002_syn_22016
crossref_primary_10_2967_jnumed_109_073445
crossref_primary_10_1016_j_neuroimage_2010_09_040
crossref_primary_10_1016_j_neuroimage_2011_08_080
crossref_primary_10_1016_j_neuroimage_2018_11_020
crossref_primary_10_2967_jnumed_114_145466
crossref_primary_10_1016_j_nucmedbio_2014_08_003
crossref_primary_10_1038_jcbfm_2012_208
crossref_primary_10_1124_jpet_116_238568
crossref_primary_10_1111_bph_15067
crossref_primary_10_1002_syn_20966
crossref_primary_10_1038_s41598_021_95715_y
crossref_primary_10_3389_fnume_2022_1080005
crossref_primary_10_1124_jpet_113_206458
crossref_primary_10_1124_jpet_112_202895
crossref_primary_10_2967_jnumed_111_092338
crossref_primary_10_1002_trc2_70020
crossref_primary_10_1002_syn_21821
crossref_primary_10_1371_journal_pbio_3001055
crossref_primary_10_2967_jnumed_117_195586
crossref_primary_10_2967_jnumed_114_138701
crossref_primary_10_1007_s10928_013_9320_6
crossref_primary_10_2967_jnumed_112_118877
crossref_primary_10_1007_s00259_019_04357_w
crossref_primary_10_1038_jcbfm_2014_150
crossref_primary_10_1021_acschemneuro_8b00103
crossref_primary_10_1093_ijnp_pyv078
crossref_primary_10_1021_acschemneuro_0c00737
crossref_primary_10_1007_s11307_019_01403_9
crossref_primary_10_1002_syn_20942
crossref_primary_10_1007_s00259_020_05030_3
crossref_primary_10_1038_s41386_024_01975_3
crossref_primary_10_1002_syn_20946
crossref_primary_10_1016_j_neuropharm_2019_107809
crossref_primary_10_1038_jcbfm_2011_177
crossref_primary_10_1016_j_neuroimage_2018_05_017
crossref_primary_10_2967_jnumed_113_128983
crossref_primary_10_1021_acschemneuro_0c00171
crossref_primary_10_1007_s11538_017_0374_2
crossref_primary_10_2967_jnumed_109_071753
crossref_primary_10_1002_cpt_2548
crossref_primary_10_1007_s00259_019_04488_0
crossref_primary_10_1177_0271678X17699223
crossref_primary_10_1177_0271678X19879230
crossref_primary_10_1038_s41386_021_00976_w
crossref_primary_10_1038_jcbfm_2015_163
crossref_primary_10_1007_s11307_023_01880_z
crossref_primary_10_1124_dmd_116_070359
crossref_primary_10_2967_jnumed_112_105114
crossref_primary_10_1021_jm401622k
crossref_primary_10_1016_j_neuroimage_2013_05_006
crossref_primary_10_1177_0271678X241238820
crossref_primary_10_1007_s00259_021_05561_3
crossref_primary_10_1016_j_ejmech_2014_03_066
crossref_primary_10_1093_cercor_bhaa387
crossref_primary_10_1126_scitranslmed_abi8593
crossref_primary_10_2967_jnumed_117_200451
crossref_primary_10_1038_npp_2014_4
Cites_doi 10.1016/S1053-8119(00)90982-0
10.1038/sj.jcbfm.9600493
10.1038/jcbfm.1990.127
10.1038/jcbfm.1983.1
10.1016/j.neuroimage.2006.11.003
10.1038/jcbfm.1985.87
10.1097/00004647-200202000-00012
10.1002/sim.1562
10.1016/S0893-133X(00)00187-1
10.3109/14639238509010848
10.1038/jcbfm.1995.17
10.1002/ana.410150302
10.1097/00004647-199609000-00008
ContentType Journal Article
Copyright 2010 ISCBFM
2015 INIST-CNRS
Copyright Nature Publishing Group Jan 2010
Copyright © 2010 Nature Publishing Group 2010 Nature Publishing Group
Copyright_xml – notice: 2010 ISCBFM
– notice: 2015 INIST-CNRS
– notice: Copyright Nature Publishing Group Jan 2010
– notice: Copyright © 2010 Nature Publishing Group 2010 Nature Publishing Group
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7TK
7X8
5PM
DOI 10.1038/jcbfm.2009.190
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Neurosciences Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList
Neurosciences Abstracts

ProQuest Central Student
MEDLINE - Academic
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
DocumentTitleAlternate Measuring drug occupancy in the absence of a reference region
EISSN 1559-7016
EndPage 50
ExternalDocumentID PMC2949110
1934578871
19738632
22499631
10_1038_jcbfm_2009_190
10.1038_jcbfm.2009.190
Genre Journal Article
GroupedDBID ---
-Q-
-TM
.55
.GJ
0R~
29K
2WC
36B
39C
3O-
4.4
53G
54M
5GY
5RE
5VS
70F
7X7
88E
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
AABMB
AACKU
AACMV
AADUE
AAEWN
AAGGD
AAGMC
AAJIQ
AAJPV
AAKGS
AANSI
AAPEO
AAQGT
AAQXH
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAVDI
AAXOT
AAYTG
AAZBJ
ABAWP
ABAWZ
ABCCA
ABCJG
ABDWY
ABEIX
ABFWQ
ABHKI
ABJNI
ABJZC
ABKRH
ABLUO
ABNCE
ABPGX
ABPNF
ABQKF
ABQNX
ABQXT
ABRHV
ABUJY
ABUWG
ABVFX
ABXGC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACGBL
ACGFO
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLHI
ACNXM
ACOFE
ACOXC
ACPRK
ACROE
ACSIQ
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADEBD
ADEIA
ADMPF
ADNON
ADRRZ
ADTBJ
ADUKL
ADVBO
ADZZY
AECGH
AENEX
AEPTA
AEQLS
AESZF
AEUHG
AEWDL
AEWHI
AEXFG
AEXNY
AFEET
AFFNX
AFFZS
AFKRA
AFKRG
AFMOU
AFOSN
AFQAA
AFUIA
AFVCE
AGHKR
AGKLV
AGNHF
AGPXR
AGWFA
AHDMH
AHMBA
AIGRN
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
AJXAJ
AJXGE
ALIPV
ALKWR
ALMA_UNASSIGNED_HOLDINGS
AMCVQ
ANDLU
AOIJS
ARTOV
AUTPY
AYAKG
B8M
BAWUL
BBNVY
BBRGL
BDDNI
BENPR
BHPHI
BKIIM
BKSCU
BPACV
BPHCQ
BSEHC
BVXVI
BWJAD
C45
CAG
CBRKF
CCPQU
CDWPY
CFDXU
COF
CORYS
CQQTX
CS3
CUTAK
D-I
DC-
DC.
DIK
DOPDO
DV7
E3Z
EBS
EE.
EJD
EMOBN
F5P
FHBDP
FYUFA
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GX1
H13
HCIFZ
HMCUK
HYE
HZ~
J8X
JSO
K.F
KQ8
LK8
M1P
M7P
O9-
OK1
OVD
P2P
P6G
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
Q1R
Q2X
RNS
RNTTT
ROL
RPM
SASJQ
SAUOL
SCNPE
SFC
SHG
SPQ
SPV
TEORI
TR2
UKHRP
W2D
X7M
YFH
YOC
ZGI
ZONMY
ZPPRI
ZRKOI
ZSSAH
ZXP
AAYXX
AJGYC
AJVBE
CITATION
AAEJI
AAPII
IQODW
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
88A
8FK
AJHME
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
PRINS
7TK
7X8
5PM
ID FETCH-LOGICAL-c579t-70a904a1919ccd6064911295db0f1b781091179cbb42febb8ae844162c9571e03
IEDL.DBID 7X7
ISSN 0271-678X
1559-7016
IngestDate Thu Aug 21 18:12:57 EDT 2025
Fri Jul 11 08:05:23 EDT 2025
Thu Jul 10 19:30:02 EDT 2025
Wed Aug 13 07:47:57 EDT 2025
Mon Jul 21 05:22:03 EDT 2025
Mon Jul 21 09:13:15 EDT 2025
Thu Apr 24 23:03:10 EDT 2025
Sun Jul 06 05:05:34 EDT 2025
Tue Jun 17 22:34:47 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords occupancy
PET
graphical analysis
Nervous system diseases
Central nervous system disease
Positron emission tomography
Cerebrovascular disease
Cerebral disorder
Emission tomography
Language English
License https://journals.sagepub.com/page/policies/text-and-data-mining-license
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c579t-70a904a1919ccd6064911295db0f1b781091179cbb42febb8ae844162c9571e03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
OpenAccessLink https://kclpure.kcl.ac.uk/portal/en/publications/ae08b9e3-2cbf-4abd-806b-9fbccf3bb2d0
PMID 19738632
PQID 219490570
PQPubID 31524
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2949110
proquest_miscellaneous_733610723
proquest_miscellaneous_21332458
proquest_journals_219490570
pubmed_primary_19738632
pascalfrancis_primary_22499631
crossref_primary_10_1038_jcbfm_2009_190
crossref_citationtrail_10_1038_jcbfm_2009_190
sage_journals_10_1038_jcbfm_2009_190
PublicationCentury 2000
PublicationDate 2010-01-01
PublicationDateYYYYMMDD 2010-01-01
PublicationDate_xml – month: 01
  year: 2010
  text: 2010-01-01
  day: 01
PublicationDecade 2010
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: New York, NY
– name: United States
– name: London
PublicationTitle Journal of cerebral blood flow and metabolism
PublicationTitleAlternate J Cereb Blood Flow Metab
PublicationYear 2010
Publisher SAGE Publications
Nature Publishing Group
Sage Publications Ltd
Publisher_xml – name: SAGE Publications
– name: Nature Publishing Group
– name: Sage Publications Ltd
References Asselin, Hammers, Sethi, Koepp, Grasby, Cunningham 2003; 23
Mintun, Raichle, Kilbourn, Wooten, Welch 1984; 15
Logan, Fowler, Volkow, Wolf, Dewey, Schlyer, MacGregor, Hitzemann, Bendriem, Gatley, Christman 1990; 10
Martinez, Hwang, Mawlawi, Slifstein, Kent, Simpson, Parsey, Hashimoto, Huang, Shinn, Heertum, Abi-Dargham, Caltabiano, Malizia, Cowley, Mann, Laruelle 2001; 24
Innis, Cunningham, Delforge, Fujita, Gjedde, Gunn, Holden, Houle, Huang, Ichise, Iida, Ito, Kimura, Koeppe, Knudsen, Knuuti, Lammertsma, Laruelle, Logan, Maguire, Mintun, Morris, Parsey, Price, Slifstein, Sossi, Suhara, Votaw, Wong, Carson 2007; 27
Patlak, Blasberg, Fenstermacher 1983; 3
Cunningham 1985; 10
Ogden 2003; 22
Gjedde, Wong 2000; 11
Slifstein, Laruelle 2000; 41
Lassen, Bartenstein, Lammertsma, Prevett, Turton, Luthra, Osman, Bloomfield, Jones, Patsalos, O'Connell, Duncan, Andersen 1995; 15
Patlak, Blasberg 1985; 5
Pinborg, Videbaek, Ziebell, Mackeprang, Friberg, Rasmussen, Knudsen, Glenthoj 2007; 34
Logan, Fowler, Volkow, Wang, Ding, Alexoff 1996; 16
Varga, Szabo 2002; 22
bibr16-jcbfm.2009.190
Asselin M-C (bibr1-jcbfm.2009.190) 2003; 23
bibr6-jcbfm.2009.190
bibr8-jcbfm.2009.190
bibr11-jcbfm.2009.190
Gjedde A (bibr4-jcbfm.2009.190) 2000; 11
bibr13-jcbfm.2009.190
bibr10-jcbfm.2009.190
bibr9-jcbfm.2009.190
Slifstein M (bibr15-jcbfm.2009.190) 2000; 41
bibr7-jcbfm.2009.190
Carson RE (bibr2-jcbfm.2009.190) 1993
bibr5-jcbfm.2009.190
bibr14-jcbfm.2009.190
bibr3-jcbfm.2009.190
bibr12-jcbfm.2009.190
4055928 - J Cereb Blood Flow Metab. 1985 Dec;5(4):584-90
7798333 - J Cereb Blood Flow Metab. 1995 Jan;15(1):152-65
11823722 - J Cereb Blood Flow Metab. 2002 Feb;22(2):240-4
17519979 - J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9
4021648 - Med Inform (Lond). 1985 Apr-Jun;10(2):137-42
6822610 - J Cereb Blood Flow Metab. 1983 Mar;3(1):1-7
17175177 - Neuroimage. 2007 Feb 15;34(4):1450-3
6609679 - Ann Neurol. 1984 Mar;15(3):217-27
11166513 - Neuropsychopharmacology. 2001 Mar;24(3):209-29
2384545 - J Cereb Blood Flow Metab. 1990 Sep;10(5):740-7
11138696 - J Nucl Med. 2000 Dec;41(12):2083-8
8784228 - J Cereb Blood Flow Metab. 1996 Sep;16(5):834-40
14601019 - Stat Med. 2003 Nov 30;22(22):3557-68
References_xml – volume: 3
  start-page: 1
  year: 1983
  end-page: 7
  article-title: Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data
  publication-title: J Cereb Blood Flow Metab
– volume: 16
  start-page: 834
  year: 1996
  end-page: 40
  article-title: Distribution volume ratios without blood sampling from graphical analysis of PET data
  publication-title: J Cereb Blood Flow Metab
– volume: 11
  start-page: S48
  year: 2000
  article-title: Receptor occupancy in absence of reference region
  publication-title: Neuroimage
– volume: 22
  start-page: 240
  year: 2002
  end-page: 4
  article-title: Modified regression model for the logan plot
  publication-title: J Cereb Blood Flow Metab
– volume: 34
  start-page: 1450
  year: 2007
  end-page: 3
  article-title: [ I]Epidepride binding to cerebellar dopamine D /D receptors is displaceable: implications for the use of cerebellum as a reference region
  publication-title: NeuroImage
– volume: 10
  start-page: 137
  year: 1985
  end-page: 42
  article-title: Non-linear regression techniques in data analysis
  publication-title: Med Informatics
– volume: 15
  start-page: 152
  year: 1995
  end-page: 65
  article-title: Benzodiazepine receptor quantification in humans using [11C]flumazenil and PET: application of the steady-state principle
  publication-title: J Cereb Blood Flow Metab
– volume: 10
  start-page: 740
  year: 1990
  end-page: 7
  article-title: Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-[C-11]-methyl-(−)-Cocaine PET studies in human subjects
  publication-title: J Cereb Blood Flow Metab
– volume: 23
  start-page: 679
  year: 2003
  article-title: Definition of a reference region for PET [ C]diprenorphine studies
  publication-title: J Cereb Blood Flow Metab
– volume: 24
  start-page: 209
  year: 2001
  end-page: 29
  article-title: Differential occupancy of somatodendritic and postsynaptic 5HT receptors by pindolol: a dose-occupancy study with [ C]WAY 100635 and positron emission tomography in humans
  publication-title: Neuropsychopharmacology
– volume: 15
  start-page: 217
  year: 1984
  end-page: 27
  article-title: A quantitative model for the assessment of drug binding sites with positron emission tomography
  publication-title: Ann Neurol
– volume: 22
  start-page: 3557
  year: 2003
  end-page: 68
  article-title: Estimation of kinetic parameters in graphical analysis of PET imaging data
  publication-title: Stat Med
– volume: 27
  start-page: 1533
  year: 2007
  end-page: 9
  article-title: Consensus nomenclature for imaging of reversibly binding radioligands
  publication-title: J Cereb Blood Flow Metab
– volume: 5
  start-page: 584
  year: 1985
  end-page: 90
  article-title: Graphical evaluation of blood-to-brain transfer constants from multiple- time uptake data. Generalizations
  publication-title: J Cereb Blood Flow Metab
– volume: 41
  start-page: 2083
  year: 2000
  end-page: 8
  article-title: Effects of statistical noise on graphic analysis of PET neuroreceptor studies
  publication-title: J Nucl Med
– volume: 11
  start-page: S48
  year: 2000
  ident: bibr4-jcbfm.2009.190
  publication-title: Neuroimage
  doi: 10.1016/S1053-8119(00)90982-0
– ident: bibr5-jcbfm.2009.190
  doi: 10.1038/sj.jcbfm.9600493
– ident: bibr7-jcbfm.2009.190
  doi: 10.1038/jcbfm.1990.127
– ident: bibr12-jcbfm.2009.190
  doi: 10.1038/jcbfm.1983.1
– ident: bibr14-jcbfm.2009.190
  doi: 10.1016/j.neuroimage.2006.11.003
– volume: 23
  start-page: 679
  year: 2003
  ident: bibr1-jcbfm.2009.190
  publication-title: J Cereb Blood Flow Metab
– ident: bibr13-jcbfm.2009.190
  doi: 10.1038/jcbfm.1985.87
– volume: 41
  start-page: 2083
  year: 2000
  ident: bibr15-jcbfm.2009.190
  publication-title: J Nucl Med
– ident: bibr16-jcbfm.2009.190
  doi: 10.1097/00004647-200202000-00012
– start-page: 499
  volume-title: Quantification of brain function: tracer kinetics and image analysis in brain PET: proceedings of Brain PET '93 Akita Quantification of Brain Function, Akita, Japan, 29–31 May, 1993
  year: 1993
  ident: bibr2-jcbfm.2009.190
– ident: bibr11-jcbfm.2009.190
  doi: 10.1002/sim.1562
– ident: bibr9-jcbfm.2009.190
  doi: 10.1016/S0893-133X(00)00187-1
– ident: bibr3-jcbfm.2009.190
  doi: 10.3109/14639238509010848
– ident: bibr6-jcbfm.2009.190
  doi: 10.1038/jcbfm.1995.17
– ident: bibr10-jcbfm.2009.190
  doi: 10.1002/ana.410150302
– ident: bibr8-jcbfm.2009.190
  doi: 10.1097/00004647-199609000-00008
– reference: 11138696 - J Nucl Med. 2000 Dec;41(12):2083-8
– reference: 6822610 - J Cereb Blood Flow Metab. 1983 Mar;3(1):1-7
– reference: 7798333 - J Cereb Blood Flow Metab. 1995 Jan;15(1):152-65
– reference: 17519979 - J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9
– reference: 2384545 - J Cereb Blood Flow Metab. 1990 Sep;10(5):740-7
– reference: 4021648 - Med Inform (Lond). 1985 Apr-Jun;10(2):137-42
– reference: 11166513 - Neuropsychopharmacology. 2001 Mar;24(3):209-29
– reference: 6609679 - Ann Neurol. 1984 Mar;15(3):217-27
– reference: 14601019 - Stat Med. 2003 Nov 30;22(22):3557-68
– reference: 11823722 - J Cereb Blood Flow Metab. 2002 Feb;22(2):240-4
– reference: 8784228 - J Cereb Blood Flow Metab. 1996 Sep;16(5):834-40
– reference: 17175177 - Neuroimage. 2007 Feb 15;34(4):1450-3
– reference: 4055928 - J Cereb Blood Flow Metab. 1985 Dec;5(4):584-90
SSID ssj0008355
Score 2.4325898
Snippet Quantitative estimation of neuroreceptor occupancy by exogenous drugs using positron emission tomography is based on the reduction in the total volume of...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
sage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 46
SubjectTerms Algorithms
Biological and medical sciences
Brain - diagnostic imaging
Brief Communication
Drug toxicity and drugs side effects treatment
Humans
Image Processing, Computer-Assisted
Medical sciences
Miscellaneous (drug allergy, mutagens, teratogens...)
Monte Carlo Method
Neurology
Pharmaceutical Preparations - metabolism
Pharmacology. Drug treatments
Piperazines - metabolism
Positron-Emission Tomography
Pyridines - metabolism
Receptor, Serotonin, 5-HT1A - drug effects
Receptors, Drug - metabolism
Serotonin Antagonists - metabolism
Vascular diseases and vascular malformations of the nervous system
Title Measuring Drug Occupancy in the Absence of a Reference Region: The Lassen Plot Re-Visited
URI https://journals.sagepub.com/doi/full/10.1038/jcbfm.2009.190
https://www.ncbi.nlm.nih.gov/pubmed/19738632
https://www.proquest.com/docview/219490570
https://www.proquest.com/docview/21332458
https://www.proquest.com/docview/733610723
https://pubmed.ncbi.nlm.nih.gov/PMC2949110
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BewCpQtDyEQqLDxWcrCaOs465oFK1qhCtEKLScopsxy5FbbLt7h7498w42bQrWq6bOTiZD7-xZ98D2JEqqNJbx1XwkhOFFjcylVxoa6wLqbRR6_D4ZHx0Kr9Mikk_mzPrxyqXNTEW6rp1dEa-i5klNYKL9NP0ipNoFF2u9goaD2GdmMtooktNhn6LwEWcYBQq41iTJ0vOxrzc_e1suOzYKjMqx7f2pI2pmeHnCZ2uxV3A89_5yVtDYHFfOnwKT3pAyfa6CHgGD3yzCVt7DTbTl3_YexZHPOPZ-SY82l_Ku23Bz-N4Oog7F6uvF2esjXTDWGrZecMQFTJjZ5T1rA3MsEGNhJGSQ9t8jCZfEXn7hk0v2jn-zul_6ghgn8Pp4cGP_SPe6yxwVyg95yo1OpUGOzftXI0djdSEworapiGzqiTuUMxbZ60UwVtbGl8iihoLpwuV-TR_AWtN2_hXwJQobG2KcVB0nYe5nee1DK5WqdDClS4BvvzSletJyEkL46KKl-F5WUXPkDimrtAzCXwY7Kcd_ca9lqMVxw3miFGwp8uzBLaXnqz6PJ1VQ1Ql8G54io6gWxPT-HZBJjmCzqJMgN1jQYyS2EWLPIGXXWDcrFWTqGouElArITMYELv36pPm_Fdk-Raa3IAL26Hgulny3a__-r9vtw2Pu6kHOjp6A2vz64V_i2BqbkcxZUaw_vng5Nv3v0ksHzE
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fT9RAEJ7g8YCJMQr-qCjsA-pTQ7vd3nZNjEGEHHJ3MQaS86l0t1vFQHtydzH8Uf6PzmyvhYvgG6_tpNl2Zme_2Z1-H8CWkIVMrDa-LKzwiULLz0QgfK50pk0RCO20DgfDbu9YfB7FoyX40_wLQ22VTU50iTqvDO2Rb-PMEgrBRfBh_Msn0Sg6XG0UNOqoOLSXv7Fim7w_-ITufc35_t7Rbs-fiwr4JpZq6ssgU4HIsExRxuQI34UiyBHnOihCLRMiysQgNVoLXlitk8wmCBm63KhYhjaI8Ln3YFlEWMl0YPnj3vDL1zb1I5xxPZNchj6uAqOGJTJKtn8aXZzX_JghLQDXVsEH42yCDilqJY2boO6_HZvX2s7cSrj_CB7OISzbqWPuMSzZchXWdkos388v2Rvmmkrdbv0qrOw2gnJr8G3g9iNxrWT5xew7qxzBMSZ3dloyxKEs0xPKM6wqWMZa_RNG2hFV-c6Z9BHr25KNz6opXvfpz3iEzE_g-E6c8BQ6ZVXa58Akj3Wexd1C0gEiZpMoykVhchlwxU1iPPCbL52aOe05qW-cpe74PUpS5xmS41QpesaDt639uCb8uNVyY8FxrTmiIqwio9CD9caT6TwzTNI2jj3YbO-iI-icJittNSOTCGFunHjAbrEgDkus23nkwbM6MK7GqkjGNeIeyIWQaQ2IT3zxTnn6w_GKc0VuwIFtUXBdDfnm13_x37fbhJXe0aCf9g-Gh-twv-65oI2rl9CZXszsK4RyU70xn0AMTu56zv4FsI1aGA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Measuring+drug+occupancy+in+the+absence+of+a+reference+region%3A+the+Lassen+plot+re-visited&rft.jtitle=Journal+of+cerebral+blood+flow+and+metabolism&rft.au=Cunningham%2C+Vincent+J&rft.au=Rabiner%2C+Eugenii+A&rft.au=Slifstein%2C+Mark&rft.au=Laruelle%2C+Marc&rft.date=2010-01-01&rft.eissn=1559-7016&rft.volume=30&rft.issue=1&rft.spage=46&rft_id=info:doi/10.1038%2Fjcbfm.2009.190&rft_id=info%3Apmid%2F19738632&rft.externalDocID=19738632
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0271-678X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0271-678X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0271-678X&client=summon